Tag Archives: MeMed

January 2024—MeMed announced that the FDA has granted 510(k) clearance for the company’s MeMed BV test for use on whole blood samples on the MeMed Key analyzer.

Sept. 20, 2021—MeMed announced FDA 510(k) clearance for use of the company’s MeMed BV test on the MeMed Key platform to help health care providers distinguish between bacterial and viral infections.

The results of a large, multicenter prospective clinical study that validates the ability of MeMed’s ImmunoXpert in vitro diagnostic blood test to determine whether a patient has an acute bacterial or viral infection was published in the March 18, 2015 online edition of Plos One.